Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-κB

American Journal of Respiratory Cell and Molecular Biology

Volumn 33, Issue 2, 2005, Pages 186-194

  Wong, Chun K ^a   Cheung, Phyllis F Y ^a   Ip, Wai K ^a   Lam, Christopher W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chemokines; Eosinophils; Interleukin 25; Mitogen activated protein kinase; Nuclear factor B

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CHEMOKINE; CYCLOHEXIMIDE; DACTINOMYCIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 25; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; 3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; C19ORF10 PROTEIN, HUMAN; COMPLEMENTARY DNA; IMIDAZOLE DERIVATIVE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; NITRILE; PYRIDINE DERIVATIVE; RECOMBINANT PROTEIN; SULFONE;

ALLERGY; ARTICLE; CYTOKINE RELEASE; EFFECTOR CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; PROTEIN INDUCTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL; WESTERN BLOTTING; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; NUCLEOTIDE SEQUENCE;

ANTHRACENES; BASE SEQUENCE; CHEMOKINES; DNA, COMPLEMENTARY; EOSINOPHILS; HUMANS; IMIDAZOLES; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRILES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RECEPTORS, INTERLEUKIN; RECOMBINANT PROTEINS; SULFONES;

EID: 24344477165     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0034OC     Document Type: Article

References (34)

1. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH, et al. A critical role for eosinophils in allergic airways remodeling. Science 2004;305:1776-1779.
2. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999;51:213-340.
3. Broide DH. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 2001;108:S65-S71.
4. KleinJan A, Dijkstra MD, Boks SS, Severijnen LA, Mulder PG, Fokkens WJ. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation. J Allergy Clin Immunol 1999;103:441-450.
5. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881-885.
6. Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, Foster JS, Goddard AD, Yansura DG, Vandlen RL, Wood WI, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001;276:1660-1664.
7. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003;14:155-174.
8. Kempuraj D, Frydas S, Conti P, Kandere-Grzybowska K, Boucher W, Letourneau R, Madhappan B, Huang SH, Sugimoto K, Papadopoulou NG, et al. Interleukin-25 (or IL-17E): a new IL-17 family member with growth factor/inflammatory actions. Int J Immunopathol Pharmacol 2003;16:185-188.
9. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, et al. 1L-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001;15:985-995.
10. Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, Kwan S, Menon S, Seymour B, Jackson C, Kung TT, et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002;169:443-453.
11. Ikeda K, Nakajima H, Suzuki K, Kagami S, Hirose K, Suto A, Saito Y, Iwamoto I. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 2003;101:3594-3596.
12. Yang L, Cohn L, Zhang DH, Homer R, Ray A, Ray P. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 1998;188:1739-1750.
13. Blackwell TS, Christman JW. The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 1997;17:3-9.
14. Wong CK, Zhang JP, Ip WK, Lam CWK. Activation of p38 mitogen-activated protein kinase and NF-κB in tumor necrosis factor-α-induced eotaxin release of human eosinophils. Clin Exp Immunol 2002;128: 483-489.
15. Ip WK, Wong CK, Lam CWK. Tumor necrosis factor-α-induced expression of intercellular adhesion molecule-1 on human eosinophilic leukemia EoL-1 cells is mediated by the activation of nuclear factor-κB pathway. Clin Exp Allergy 2003;33:241-248.
16. Wong CK, Ip WK, Lam CWK. IL-3, -5, and GM-CSF-induced adhesion molecule expression on eosinophils by p38 MAPK and NF-κB. Am J Respir Cell Mol Biol 2003;29:133-147.
17. Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002;100: 1828-1834.
18. Wan S, Yim AP, Wong CK. Expression of FHL2 and cytokine messenger RNAs in human myocardium after cardiopulmonary bypass. Int J Cardiol 2002;86:265-272.
19. Jordan NJ, Kolios G, Abbot SE, Sinai MA, Thompson DA, Petraki K, Westwick J. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J Clin Invest 1999;104:1061-1069.
20. Huang RP. Detection of multiple proteins in an antibody-based protein-microarray system. J Immunol Methods 2001;255:1-13.
21. Wong CK, Lam CWK. Clinical applications of cytokine assays. Adv Clin Chem 2003;37:1-46.
22. Tarnok A, Hambsch J, Chen R, Varro R. Cytometric bead array to measure six cytokines in twenty-five microliters of serum. Clin Chem 2003;49:1000-1002.
23. Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, Lam CW. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001;125:177-183.
24. Lukacs NW, Tekkanat KK. Role of chemokines in asthmatic airway inflammation. Immunol Rev 2000;177:21-30.
25. Ferreira MA. Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies. Mediators Inflamm 2003;12:259-267.
26. Dunzendorfer S, Kaneider NC, Kaser A, Woell E, Frade JM, Mellado M, Martinez-Alonso C, Wiedermann CJ. Functional expression of chemokine receptor 2 by normal human eosinophils. J Allergy Clin Immunol 2001;108:581-587.
27. Conti P, Boucher W, Letourneau R, Feliciani C, Reale M, Barbacane RC, Vlagopoulos P, Bruneau G, Thibault J, Theoharides TC. Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT release. Immunology 1995;86:434-440.
28. Rose CE Jr, Sung SS, Fu SM. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculaiion 2003;10:273-288.
29. Oliveira SH, Lira S, Martinez-A C, Wiekowski M, Sullivan L, Lukacs NW. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8. J Leukoc Biol 2002;71:1019-1025.
30. Wong CK, Wang CB, Ip WK, Tian YP, Lam CW. Role of p38 MAPK and NF-kB for chemokine release in coculture of human eosinophils and bronchial epithelial cells. Clin Exp Immunol 2005;139:90-100.
31. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001;98:13681-13686.
32. Wong CK, Ip WK, Lam CWK. Biochemical assessment of intracellular signal transduction pathways in eosinophils: implications for pharmacotherapy. Crit Rev Clin Lab Sci 2004;41:79-113.
33. Newton R, Holden N, Inhibitors of p38 mitogen-activated protein kinase: potential as anti-inflammatory agents in asthma? BioDrugs 2003;17: 113-129.
34. Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 2000;6:441-448.